| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 569.966 | 968.889 | 1.134.578 | 1.178.520 | 1.306.646 |
| Total Income - EUR | - | - | - | - | - | 569.966 | 968.898 | 1.134.579 | 1.178.520 | 1.308.212 |
| Total Expenses - EUR | - | - | - | - | - | 477.886 | 811.026 | 955.095 | 1.062.102 | 1.121.389 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 92.080 | 157.872 | 179.484 | 116.418 | 186.824 |
| Net Profit/Loss - EUR | - | - | - | - | - | 87.390 | 149.515 | 169.327 | 101.925 | 157.454 |
| Employees | - | - | - | - | - | 13 | 0 | 19 | 21 | 24 |
Check the financial reports for the company - Epidemiolife Clinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 118.050 | 158.321 | 178.392 | 123.926 | 147.843 |
| Current Assets | - | - | - | - | - | 56.927 | 31.405 | 183.652 | 41.754 | 196.710 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 209 | 0 |
| Receivables | - | - | - | - | - | 5.690 | 12.886 | 163.729 | 16.444 | 155.734 |
| Cash | - | - | - | - | - | 51.238 | 18.518 | 19.922 | 25.101 | 40.977 |
| Shareholders Funds | - | - | - | - | - | 134.060 | 149.637 | 169.448 | 118.137 | 157.575 |
| Social Capital | - | - | - | - | - | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | - | 40.917 | 40.088 | 192.595 | 47.544 | 186.978 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epidemiolife Clinic S.r.l.